{
    "organizations": [],
    "uuid": "936a3aa9715132f717775752bfa4ab193a2a4556",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-diasorin-receives-fda-clearance-fo/brief-diasorin-receives-fda-clearance-for-liaison-brahms-percent-ii-gen-assay-for-sepsis-idUSFWN1RI03U",
    "ord_in_thread": 0,
    "title": "BRIEF-Diasorin Receives FDA Clearance For Liaison Brahms Percent II Gen Assay For Sepsis",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5 (Reuters) - DIASORIN SPA:\n* RECEIVES FDA CLEARANCE FOR LIAISON BRAHMS PERCENT II GEN ASSAY TO DETECT SEVERE BACTERIAL INFECTIONS Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-05T15:58:00.000+03:00",
    "crawled": "2018-04-06T21:42:44.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "diasorin",
        "spa",
        "receives",
        "fda",
        "clearance",
        "liaison",
        "brahms",
        "percent",
        "ii",
        "gen",
        "assay",
        "detect",
        "severe",
        "bacterial",
        "infection",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}